Age-Related Differences in Molecular Profiles for Immune Checkpoint Blockade Therapy

Immune checkpoint blockade (ICB) therapies have significantly improved the prognosis and shown considerable promise for cancer therapy; however, differences in ICB treatment efficacy between the elderly and young are unknown. We analyzed the studies enrolled in the meta-analysis using the deft appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi-jie, Luan, Jiao-chen, Song, Le-bin, Cong, Rong, Ji, Cheng-jian, Zhou, Xiang, Xia, Jia-dong, Song, Ning-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082107/
https://www.ncbi.nlm.nih.gov/pubmed/33936087
http://dx.doi.org/10.3389/fimmu.2021.657575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082107/
https://www.ncbi.nlm.nih.gov/pubmed/33936087
http://dx.doi.org/10.3389/fimmu.2021.657575

Ejemplares similares